Newron Pharmaceuticals S.p.A. (SWX: NWRN)
Switzerland
· Delayed Price · Currency is CHF
8.57
+0.08 (0.94%)
Sep 4, 2024, 4:36 PM CET
Newron Pharmaceuticals Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 162 | 287 | 226 | 204 | 291 | 215 | |
Market Cap Growth | 26.85% | 26.85% | 10.73% | -29.80% | 35.75% | -8.41% | |
Enterprise Value | 195 | 341 | 328 | 263 | 356 | 240 | |
Last Close Price | 8.48 | 0.49 | 0.51 | 0.61 | 1.12 | 1.40 | |
PE Ratio | - | -3.77 | -2.10 | -2.32 | -2.67 | -2.28 | |
PS Ratio | 17.95 | 16.70 | 12.60 | 10.80 | 13.46 | 13.42 | |
PB Ratio | -5.25 | -5.25 | -4.19 | -7.87 | -13.54 | -16.86 | |
P/FCF Ratio | -5.13 | -5.13 | -4.65 | -3.68 | -5.69 | -4.01 | |
P/OCF Ratio | -6.35 | -6.35 | -4.87 | -3.94 | -6.42 | -4.52 | |
EV/Sales Ratio | 23.13 | 19.81 | 18.23 | 13.87 | 16.44 | 14.98 | |
EV/EBITDA Ratio | -5.68 | -5.68 | -5.12 | -4.21 | -5.41 | -3.40 | |
EV/EBIT Ratio | -5.36 | -5.36 | -4.88 | -3.98 | -5.13 | -3.23 | |
EV/FCF Ratio | -20.63 | -6.08 | -6.73 | -4.73 | -6.94 | -4.48 | |
Debt / Equity Ratio | -1.69 | -1.69 | -1.74 | -2.81 | -2.19 | -3.40 | |
Debt / FCF Ratio | -1.65 | -1.65 | -1.93 | -1.32 | -0.92 | -0.81 | |
Asset Turnover | 0.17 | 0.17 | 0.20 | 0.23 | 0.30 | 0.20 | |
Inventory Turnover | 0.77 | 0.77 | 1.17 | 1.06 | 2.12 | 1.60 | |
Quick Ratio | 0.18 | 0.18 | 0.15 | 0.16 | 0.17 | 0.25 | |
Current Ratio | 0.60 | 0.60 | 0.43 | 0.54 | 0.43 | 0.79 | |
Return on Equity (ROE) | - | - | - | - | - | -2960.65% | |
Return on Assets (ROA) | -40.36% | -40.36% | -46.51% | -50.63% | -59.24% | -57.78% | |
Return on Capital (ROIC) | -102.29% | -102.29% | -96.55% | -113.32% | -154.27% | -102.53% | |
Earnings Yield | -9.98% | -23.51% | -37.79% | -39.11% | -26.86% | -38.85% | |
FCF Yield | -5.85% | -19.51% | -21.52% | -27.15% | -17.58% | -24.91% | |
Buyback Yield / Dilution | -48.58% | -48.58% | -16.05% | -61.23% | -38.22% | -72.60% | |
Total Shareholder Return | -48.58% | -48.58% | -16.05% | -61.23% | -38.22% | -72.60% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.